HRCT imaging of pulmonary involvement in granulomatosis with polyangiitis and microscopic polyangiitis at disease onset and during follow-up

• Published in: Seminars in arthritis and rheumatism Vol. 63; p. 152307
• Main Authors: Villeneuve, Thomas, Faguer, Stanislas, Collot, Samia, Pugnet, Grégory, Prévot, Grégoire
• Format: Journal Article
• Language: English
• Published: United States 01.12.2023
• Subjects: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications; Antibodies, Antineutrophil Cytoplasmic; Follow-Up Studies; Granulomatosis with Polyangiitis - complications; Granulomatosis with Polyangiitis - diagnostic imaging; Hemorrhage; Humans; Lung Diseases, Interstitial - complications; Microscopic Polyangiitis - complications; Microscopic Polyangiitis - diagnostic imaging; Recurrence; Retrospective Studies; Therapeutic response; Granulomatosis with polyangiitis; CT imaging; Microscopic polyangiitis; Relapse; Lung involvement
• ISSN: 0049-0172; 1532-866X
• DOI: 10.1016/j.semarthrit.2023.152307

The pulmonary involvement in patients with microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) is well known at disease onset but data during follow-up (after the induction regimen and when the first relapse occurs) are limited. Our goal was to analyze chest high-resolution computed tomography (HRCT) findings of (ANCA)-associated vasculitis patients. All consecutive unselected AAV patients over eighteen with positive ANCA status and with HRCT chest performed at the diagnosis were retrospectively enrolled between 2004 and 2019 at the Toulouse University Hospital (France). Two experienced pulmonologists and one expert respiratory radiologist reviewed independently HRCT chest scans. A total of 157 AAV patients were included in the study. Two-thirds of AAV patients had pulmonary involvement at diagnosis. Diffuse alveolar hemorrhage (DAH) was observed in 31.2 % of cases, nodules and masses in 18.5 %, bronchial airway involvement in 13.4 %, and interstitial involvement in 12.7 %. Following the induction regimen, chest HRCT scans over a two-year period demonstrated significant improvement in DAH and nodular manifestations, whereas bronchial airway involvement exhibited variability and half of cases of interstitial lung disease (ILD) had progressive course. Outcomes and survival rates are better for nodular and bronchial involvement. DAH was the most frequent cause of deaths. Progressive fibrotic changes in ILD over time could impact prognosis despite AAV remission. Employing a pattern-based approach with HRCT chest scans to assess lung involvement could be valuable in predicting treatment response, relapse, mortality, and could improved the management of AAV patients.